Saturday, July 5, 2025

Latest

Khiron Receives Authorization For Sale Of High-THC Medical Cannabis

Khiron Life Sciences (TSXV: KHRN) announced this morning that it has received authorization from the Colombian government to begin selling high-THC medical cannabis to patients. Khiron is the first, and currently only, company to receive authorization from the Colombian government for both the manufacturing and sale of high-THC medical cannabis.

The company itself refers to the authorization as having been for “magistral preparation” for high-THC medical cannabis, a term which is defined as “any medicinal product prepared in a pharmacy in accordance with a medical prescription for an individual patient.” The authorization enables the company to immediately begin selling high-THC medical products through its ILAN pharmacy network.

ILAN is fully authorized to sell high-THC products to patients for indications that include nausea, chronic pain, and vomiting associated with chemotherapy. Expanded distribution is expected to also occur as partner pharmacies receive approval to sell high-THC medical cannabis to patients, with the company giving a target of the third quarter of 2020 for this expanded distribution.

"The authorization from Colombia's National Narcotics Fund demonstrates our continued ability to meet regulatory requirements, and as a result we today begin to sell high-THC medical cannabis product in Colombia. With our clinics, training and infrastructure in place our high-THC product offers an important alternative for patients living with chronic pain, nausea and vomiting associated with chemotherapy, and continues Khiron's mission to improve the quality of life for patients in Colombia and across Latin America" 
Juan Diego Alvarez

Khiron Life Sciences last traded at $0.82 on the TSX Venture.


FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Torex Gold Acquires Reyna Silver For CASH!

Dundee Acquires Adriatic Metals: The Balkan Growth Strategy

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Khiron Life “Renews” Buyback Program, Last Program Was A Bust

Khiron Life Sciences (TSXV: KHRN) this morning announced that it is renewing its normal course...

Tuesday, September 14, 2021, 08:19:09 AM

The Deep Dive Spotlight Series: Chris Naprawa of Khiron Life Sciences

The Deep Dive is stepping up our programming. We’re upgrading our Canadian small cap coverage...

Saturday, June 6, 2020, 09:00:00 AM

Khiron Life Sciences: An Essential Service of Colombia

Khiron Life Sciences (TSXV: KHRN) is uniquely positioned as a global integrated medical cannabis company....

Friday, April 24, 2020, 12:29:21 PM

Spotlight Series: Khiron Life Sciences Revisited

Our first recurring guest on our Spotlight Series is that of Chris Naprawa, whom is...

Saturday, September 5, 2020, 08:30:00 AM

Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a...

Tuesday, May 31, 2022, 10:34:00 AM